Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Caristo-Agepha-Pharma

More Like This

PR Newswire associated0

American College of Cardiology Presentation Highlights Promising Results Showing Potential to Reduce Coronary Inflammation with Abcentra's Orticumab

PR Newswire associated0

Caristo Secures FDA Clearance, Ushering in a New Era of AI-Powered Heart Attack Prevention

PR Newswire associated0

The Lancet Publishes Results from World's Largest Coronary CT Registry Showing New AI Technology Can Predict Cardiac Events Due to Coronary Inflammation At Least 10 Years in Advance

PR Newswire associated0

Caristo Diagnostics Recognized as Quarterfinalist in the Digital Health Awards, Rising Star Category

PR Newswire associated0

American Heart Association Late-Breaking Science Presentation Reveals Majority of Adverse Cardiac Events Occur Among Patients Without Obstructive Coronary Artery Disease but Risks Are Detectable by Novel AI

PR Newswire associated0

Newsweek Selects Caristo Diagnostics as One of World's Best Digital Health Companies

PR Newswire associated0

Caristo Diagnostics Offers £500 to First 100 UK Patients Who Get Advanced Heart Health Screening

PR Newswire associated0

AMA Approves CPT Codes for Caristo's AI-Powered Heart Disease Risk Stratification and Prevention Technology